4 assets in Pleural Disorder

Therapeutic assets addressing Pleural Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cis-Diamminedichloroplatinum Ii Pleural Disorder	Wuhan YZY Biopharma Co., Ltd.	P1/2	CCC (48)
m701 pleural infusion Pleural Disorder	Wuhan YZY Biopharma Co., Ltd.	P1/2	CCC (48)
Photofrin Ii Pleural Disorder	Roswell Park Cancer Institute	P1	CC (47)
Wsk-Im02 Pleural Disorder	WestVac Biopharma Co., Ltd.	P1	CC (43)